|
CALGARY, ALBERTA--(Marketwired - Aug. 10, 2015) - Vivione Biosciences Inc. ("Vivione" or the "Corporation") (TSX VENTURE:VBI) wishes to provide an operations update. In connection with the diminished shareholder value that has occurred over the past six months and as a consequence of the anticipated difficulties in servicing the liabilities of the Corporation as they become due, the Corporation will be reviewing alternative financing solutions that would enable it to meet its financial obligations and fund the continued development of its products. |
